15.88%| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 15.88 | 23.58 | 0.09 | 6.48 | NA |
| Classification | 14.59 | 17.02 | -1.33 | 3.01 | 6.37 |
| Index (S&P 500) | 20.90 | 21.30 | -6.10 | 0.30 | -0.70 |
| % Rank in Class (1-best,100=worst) | 43 | 21 | 31 | 15 | NA |
| Investment Objective: | Health/Biotech |
|---|---|
| Net Assets ($Mil) | 172.40 |
| Inception Date: | 6/18/01 |
| Manager Name, Tenure | Andrew Oh, 2006 |
| Expense Ratio: | 1.00% |
|
Sales Charge:
Load Type:
|
No Load 0.00% 0.00% |
| Company Name | Symbol | % Net Assets |
|---|---|---|
| Johnson & Johnson | JNJ | 15.89 |
| Pfizer | PFE | 15.54 |
| Merck | MRK | 9.25 |
| Abbott Laboratories | ABT | 8.59 |
| Schering Plough Corp | SGP | 4.94 |
| Allergan Inc | AGN | 4.82 |
| Bristol Myers | BMY | 2.35 |
| Shire | SHPGY | 2.28 |
| Vanda Pharmaceuticals Inc | VNDA | 2.10 |
| Medco Health Sol | MHS | 1.74 |
| % of Total Holdings | 67.5 | |